United States of America
Immunohistochemistry
Dako is a global leader in tissue-based cancer diagnostics. Dako provides reagents, instruments, software and service for high quality cancer diagnosis and efficient laboratory processes. As a world-leading expert, Dako continuously challenges and raises the global standards for fast and accurate answers for cancer patients and doctors making vital decisions for treatment.
Knowledge
Dako's immunohistochemistry products brings pathology laboratories even closer to obtain high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety. Dako has more than 40 years of experience working with pathology laboratories to ensure optimal staining quality. The broad reagent portfolio is continuously enhanced with new generations of carefully selected and clinically relevant reagents and instruments. To ensure that the correct results are obtained, new product performance is evaluated during development in close collaboration with customers and endorsed by pathology experts.
Improved Standardization
Operator independency is obtained with standard staining protocols for more than a hundred FLEX RTU antibodies and several dual-color antibody cocktails. This is achieved using an integrated instrument and software platform optimized for consistent and reliable results in any pathology laboratory. Dako's immunohistochemistry portfolio is a solution offering with high focus on quality and service which brings simplification of work processes, removes variation and minimizes possible staining imperfections.
Knowledge
Dako's immunohistochemistry products brings pathology laboratories even closer to obtain high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety. Dako has more than 40 years of experience working with pathology laboratories to ensure optimal staining quality. The broad reagent portfolio is continuously enhanced with new generations of carefully selected and clinically relevant reagents and instruments. To ensure that the correct results are obtained, new product performance is evaluated during development in close collaboration with customers and endorsed by pathology experts.
Improved Standardization
Operator independency is obtained with standard staining protocols for more than a hundred FLEX RTU antibodies and several dual-color antibody cocktails. This is achieved using an integrated instrument and software platform optimized for consistent and reliable results in any pathology laboratory. Dako's immunohistochemistry portfolio is a solution offering with high focus on quality and service which brings simplification of work processes, removes variation and minimizes possible staining imperfections.